Placebo News and Research

RSS

Cannabis could help people with opioid addiction

A new study has shown that cannabidiol or CBD, found in cannabis, could help people with opioid use disorder or addiction. CBD can help reduce the symptoms of craving among addicts when on withdrawal from the opioid and also reduce the accompanying anxiety and restlessness write the authors of the study.

22 May 2019

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Cannabidiol reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the cycle of addiction, according to research conducted at the Icahn School of Medicine at Mount Sinai and published May 21 in the American Journal of Psychiatry.

21 May 2019

Repetitive transcranial magnetic stimulation improves working memory, study shows

Magnetic stimulation of the brain improves working memory, offering a new potential avenue of therapy for individuals living with Alzheimer's disease and other forms of dementia, according to new research from the Duke University School of Medicine.

16 May 2019

Probiotic-derived molecule optimizes the immune system to combat viral inflammatory diseases

The existence of certain microorganisms in your gut may bolster the immune system's ability to fend off a herpes viral attack that can cause fatal brain inflammation, reports a new City of Hope-led study.

14 May 2019

Prophylactic antibiotics could halve infection rates after childbirth

Thousands of women could have been spared pain and infection if they were given prophylactic antibiotics following assisted childbirth, advise researchers.

14 May 2019

Statins' potential to treat MS unrelated to the drug's cholesterol lowering effects

The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis - for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL study has found.

10 May 2019

UIC to lead $14.6 million, multi-center COPD research project

The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs -- azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication -- is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD.

10 May 2019

Early clinical trial of new treatment for severe dry eye disease shows promising results

Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision Science and Technology.

7 May 2019

Montmorency tart cherries could exert beneficial effects for adults with metabolic syndrome

Montmorency tart cherries reduced systolic blood pressure, insulin levels and insulin concentrations in adults with metabolic syndrome participating in a small pilot study published in the Journal of Functional Foods.

7 May 2019

Transplanting gut bacteria from stress-vulnerable rats alters behavior, brain inflammation in recipient

Scientists have shown that transplanting gut bacteria, from an animal that is vulnerable to social stress to a non-stressed animal, can cause vulnerable behavior in the recipient.

7 May 2019

New drug successfully lowers levels of toxic protein that causes Huntington disease

An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients.

7 May 2019

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder.

3 May 2019

Targeting antidiuretic hormone vasopressin shows promise for autism

Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.

2 May 2019

Protein supplements containing BCAA may have ‘detrimental effects’ on health and lifespan

New research suggests that BCAAs in the form of pre-mixed protein powders, shakes and supplements may do more harm to health than good.

1 May 2019

Diabetes drug could help with smoking cessation

Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston

30 Apr 2019

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

Intensive blood pressure treatment benefits people with type 2 diabetes regardless of cardiovascular risk

People with type 2 diabetes who received intensive treatment to keep their blood pressure levels at 130/80 mm/Hg or below had fewer heart attacks, strokes and other diabetes complications, according to a study published in the American Heart Association's journal Hypertension.

29 Apr 2019

Peppermint oil helps people with non-cardiac chest pain and difficulty swallowing

Imagine that while eating a delicious meal at your favorite restaurant, your joy is cut short because of difficulty swallowing your food, followed by chest pain.

27 Apr 2019

FDA approves new treatment for children with lupus

The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous infusion for treatment of children with systemic lupus erythematosus – often referred to as simply "lupus" – a serious chronic disease that causes inflammation and damage to various body tissues and organs.

27 Apr 2019

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Treating children who have a peanut allergy by gradually exposing them to increasing levels of peanut extract may actually increase their risk of allergic attacks, warn researchers.

26 Apr 2019

Placebo News and Research

Cannabis could help people with opioid addiction

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Repetitive transcranial magnetic stimulation improves working memory, study shows

Probiotic-derived molecule optimizes the immune system to combat viral inflammatory diseases

Prophylactic antibiotics could halve infection rates after childbirth

Statins' potential to treat MS unrelated to the drug's cholesterol lowering effects

UIC to lead $14.6 million, multi-center COPD research project

Early clinical trial of new treatment for severe dry eye disease shows promising results

Montmorency tart cherries could exert beneficial effects for adults with metabolic syndrome

Transplanting gut bacteria from stress-vulnerable rats alters behavior, brain inflammation in recipient

New drug successfully lowers levels of toxic protein that causes Huntington disease

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Targeting antidiuretic hormone vasopressin shows promise for autism

Protein supplements containing BCAA may have ‘detrimental effects’ on health and lifespan

Diabetes drug could help with smoking cessation

Study results of a potential drug to treat Type 2 diabetes in children announced

Intensive blood pressure treatment benefits people with type 2 diabetes regardless of cardiovascular risk

Peppermint oil helps people with non-cardiac chest pain and difficulty swallowing

FDA approves new treatment for children with lupus

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News